Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Instagram Outage Disrupts Thousands of U.S. Users 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
BRIGHTON, Colo., March 19, 2017 -- Brighton Eye Associates is pleased to announce to the community the introduction of the High Definition CIRRUS HD-OCT technology as part of an enhanced eye examination. The Ocular Coherence Tomography or OCT provides a microscopic 3-D evaluation of the eye. Especially important is its use for macular degeneration and for glaucoma. It is also valuable for other eye conditions including diabetes and high blood pressure. Doctors are able to see the difference between wet macular degeneration and dry macular degeneration.
Glaucoma is usually seen in people over the age of 40. People do not know they have glaucoma because it has no symptoms. Early detection, monitoring, and treatment slows the progress of glaucoma. The new High Definition CIRRUS HD-OCT instrument allows for a 3D examination of the eye and much earlier diagnosis of glaucoma.
“We are excited to offer the new HD OCT instrument to our patients,” said Dr. Rodney D. Fair, OD. “Dr. Baker, Dr. Sanchez and I are always looking for better ways to serve the vision needs of our patients and this instrument is the latest addition to our state-of-the-art technology used to help our patients at Brighton Eye Associates.”
Visit http://brightoneye.net/ for more details.
Brighton Eye Associates 1001 E. Bridge Street Brighton, CO 80601 (303) 659-3036
